from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3737/-

LFCtreatmentdescriptionclass of inhibitor

-0.711

Amikacinug/mL Amikacintranslation

-0.295

Cap5-10ug/mL Capreomycintranslation

-0.179

Rox10-50 ug/mL Roxithromycintranslation

0.307

SM2-5 ug/mL Streptomycintranslation

-0.797

Tet5-10 ug/mL Tetracyclinetranslation

0.211

Rif0.2-5ug/mL Rifampicintranscription

-0.192

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.817

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.768

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.347

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.507

Clofazimine10-13 ug/mL Clofaziminerespiration

0.015

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.486

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.350

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.648

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.214

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.714

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.099

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.380

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.470

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.083

KCN5-20 ug/mL Potassium cyaniderespiration

-0.698

NaN30.2-2 mM Sodium aziderespiration

0.785

Nigericin50 uM Nigericinrespiration

-0.612

TRC10-150 ug/mL Triclosanrespiration

-1.803

TRZ10-25 ug/mL Thioridazinerespiration

1.407

Valinomycin0.5-10 uM Valinomycinrespiration

0.772

ZnSO42 mM ZnSO4respiration

-0.808

menadione6-10 ug/mL Menadionerespiration

0.167

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.436

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.411

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.442

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.777

NRP_1Non-replicating persistence stage 1dosRassociated

0.625

Amp0.2mg/mL AmpicillincellWall

0.532

Cephalexin20-100 ug/mL CephalexincellWall

1.193

Cerulenin0.32-5 ug/mL CerulenincellWall

0.616

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.805

EMB10-20 ug/mL EthambutolcellWall

0.853

Eta12-40 ug/mL EthionamidecellWall

0.969

INH0.2-0.4 ug/mL IsoniazidcellWall

0.504

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.392

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.331

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.029

BZA0.12 mg/mL BenzamidearomaticAmides

-0.089

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.107

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.002

H2O24 mM hydrogen peroxideDNAdamaging

0.838

Levo10 ug/mL LevofloxacinDNAdamaging

0.559

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.258

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.502

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.797

UVUV-irradiationDNAdamaging

-0.346

ARP41-4 ug/mL Antitubercular compound ARP4?

0.394

Antimycin12.5-50 ug/mL Antimycin A?

0.827

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.327

PA_110-50 ug/mL Antitubercular compound PA-1?

0.132

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.574

PA8240.2-2 ug/mL PA-824?

-0.376

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.061

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.517

Verapamil50 uM Verapamil?

0.663

mercaptoethanol2 mM 2-Mercaptoethanol?

1.347

methoxatin10-20 ug/mL Methoxatin?